Large gap with delayed quotes
|
Last quote
09/11/2026
-
17:30:17
|
Bid
09/11/2026 -
17:40:00
|
Bid Volume |
Ask
09/11/2026 -
17:40:00
|
Ask Volume |
|---|---|---|---|---|
|
66.70
+2.20
(
+3.41% )
|
65.40
|
100 |
66.90
|
13 |
Analysis date: 08.09.2026
Global Evaluation
Neutral
Neutral
The stock is classified in the neutral zone since 08.09.2026.
Interest
Weak
Weak
Two stars since 18.08.2026.
Earnings Rev Trend
Negative
Negative
Compared to seven weeks ago, the analysts have lowered their earnings per share estimates. This negative trend began 07.08.2026 at a price of 51.80.
Evaluation
Strongly overvalued
Strongly overvalued
Based on its growth potential and our own criteria, we believe the share price is currently overvalued.
MT Tech Trend
Positive
Positive
The dividend-adjusted forty day technical trend is positive since 14.08.2026.
4wk Rel Perf
26.13%
26.13%
The four-week dividend-adjusted overperformance versus STOXX600 is 26.13%.
Sensibility
Middle
Middle
The stock has been on the moderate-sensitivity level since 08.09.2026.
Bear Market Factor
Low
Low
On average, the stock has a tendency to minimize the drops in the index by -0.38%.
Bad News Factor
Low
Low
When the stock's pressure is specific, the market sanction on average is 2.83%.
Mkt Cap in $bn
0.95
0.95
With a market capitalization <$2bn, BASILEA PHARMACEUTIC is considered a small-cap stock.
G/PE Ratio
-0.11
-0.11
A negative ratio (Forecasted Growth + Estimated Dividend Yield/ Estimated Price Earnings) indicates that either the forecasted growth is decelerating (negative annualized growth estimate) or the financial analysts are expecting a loss (negative estimated PE).
LT P/E
264.40
264.40
The estimated PE is for the year 2028.
LT Growth
-29.70%
-29.70%
The annualized growth estimate is for the current year to 2028.
Avg. Nb analysts
3
3
Over the last seven weeks, an average of 3 analysts provided earnings per share estimates.
Dividend Yield
0.00%
0.00%
The company is not paying a dividend.
Beta
66
66
For 1% of index variation, the stock varies on average by 0.66%.
Correlation
0.25
0.25
Stock movements are strongly independent of index variations.
Value at Risk
15.34
15.34
The value at risk is estimated at CHF 15.34. The risk is therefore 23.78%. This value is based on the historical volatility for a medium time period (1 month) with a confidence of 95%.
First Analysis Date
12.11.2004
12.11.2004